U.K.-based Mereo BioPharma Group PLC plans to conduct a registered IPO in the U.S.
The number of shares and price of the proposed offering have not been determined.
The offering is expected to commence in the first half of 2018, subject to market and other conditions including the U.S. Securities and Exchange Commission review process of the relevant documents.
